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Abstract
Vascularization of the placenta is a critical developmental process that ensures fetal viability. Although the vascular health of
the placenta affects both maternal and fetal well being, relatively little is known about the early stages of placental vascular
development. The ubiquitin ligase Ankyrin repeat, SOCS box-containing 4 (ASB4) promotes embryonic stem cell
differentiation to vascular lineages and is highly expressed early in placental development. The transcriptional regulator
Inhibitor of DNA binding 2 (ID2) negatively regulates vascular differentiation during development and is a target of many
ubiquitin ligases. Due to their overlapping spatiotemporal expression pattern in the placenta and contrasting effects on
vascular differentiation, we investigated whether ASB4 regulates ID2 through its ligase activity in the placenta and whether
this activity mediates vascular differentiation. In mouse placentas, ASB4 expression is restricted to a subset of cells that
express both stem cell and endothelial markers. Placentas that lack Asb4 display immature vascular patterning and retain
expression of placental progenitor markers, including ID2 expression. Using JAR placental cells, we determined that ASB4
ubiquitinates and represses ID2 expression in a proteasome-dependent fashion. Expression of ASB4 in JAR cells and primary
isolated trophoblast stem cells promotes the expression of differentiation markers. In functional endothelial co-culture
assays, JAR cells ectopically expressing ASB4 increased endothelial cell turnover and stabilized endothelial tube formation,
both of which are hallmarks of vascular differentiation within the placenta. Co-transfection of a degradation-resistant Id2
mutant with Asb4 inhibits both differentiation and functional responses. Lastly, deletion of Asb4 in mice induces a pathology
that phenocopies human pre-eclampsia, including hypertension and proteinuria in late-stage pregnant females. These
results indicate that ASB4 mediates vascular differentiation in the placenta via its degradation of ID2.
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Introduction
Vasculogenesis, the formation of new blood vessels from the de
novo production of endothelial cells, is divided into two categories:
extraembryonic (occurring in the yolk sac and allantois) and
embryonic (restricted to the embryo itself) [1]. Extraembryonic
blood vessel formation precedes embryonic vasculogenesis and
provides communication between the fetal circulation and the yolk
sac to facilitate the transfer of nutrients and blood gases to the
developing embryo [2]. Extraembryonic vasculogenesis supplies
the allantois with primitive vessels in preparation for chorion
fusion and is responsible for placental development and umbilical
vessel formation, thus initiating the vascular connection between
the fetal and maternal placental tissues [3]. This vascularization of
the early placenta is crucial for the health and viability of not only
the fetus, but also the mother [4–6]. However, little is known
about the key mediators of early placental vascular development.
During human pregnancy, a population of undifferentiated
multipotent placental cells, termed cytotrophoblasts (CTBs),
differentiate into villous and extravillous trophoblasts that form
and remodel the placental vasculature [7]. Villous trophoblasts
have endothelial cell functions in the chorionic villi and also fuse
into syncytiotrophoblasts [8]. Extravillous trophoblasts invade and
migrate through the junctional zone of the placenta into the
maternal decidua, where they replace the endothelial cells that line
the spiral arteries [5]. These differentiated endothelial-like CTBs
cells form tight junctions in the arteries, creating high capacity, low
resistance blood vessels that allow for the exchange of blood gasses
and nutrients from the mother to the developing fetus [9]. Though
not entirely analogous, many of these same processes are
conserved in mice [10]. That is, cells originating from a
trophoblast (TB) stem cell progenitor migrate and invade the
maternal arteries, but are thought to derive from trophoblast giant
cell intermediaries, rather than cytotrophoblast lineages [11].
Disruption of the migration and invasion of differentiating TB cells
can result in poorly formed vessels that lead to vascular
insufficiency of the placenta and fetus, which in turn may result
in pre-eclampsia [6]. Pre-eclampsia is characterized as the sudden
onset of maternal hypertension, proteinuria, and edema [12]. The
underlying pathophysiology of pre-eclampsia is thought to be
rooted in vascular dysfunction [13], which may be due to aberrant
early TB differentiation [14], though the precise genesis of this
disease remains unknown.
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Previous work in this laboratory demonstrated that Ankyrin
repeat, SOCS box-containing 4 (ASB4) is an oxygen-sensitive E3
ligase that is abundantly expressed in the developing placenta and
is highly upregulated during the differentiation of embryonic stem
(ES) cells into endothelial cell lineages [15]. In addition, Asb4
transcription decreases when challenged by laminar shear stress in
endothelial cells [16] highlighting the importance of ASB4 in the
vasculature. ASB4 is one of 18 proteins in the ASB family, which
are part of the suppressors of cytokine signaling (SOCS) super-
family. ASB4 contains nine ankyrin repeats, seven of which are
highly conserved, and a C-terminal SOCS box [17]. Ankyrin
repeats are common 33-residue motifs that mediate protein-
protein interactions and are found in proteins with functions
ranging from development to transcription and cell cycle control
[18]. Like other members of the ASB family [19], ASB4 associates
with cullin, elongin, and ROC/Rbx RING-finger proteins
(possibly because ASB4 lacks a RING-finger domain), which are
all part of the ubiquitin ligase complex [15]. There is little
evidence indicating a central function of ASB4. However, areas of
high energy consumption (e.g., testes, heart, and brain) in adult
mice have ASB4 ligase activity [20–22], reinforcing our hypothesis
that ASB4 regulates vascular development and differentiation
[23,24]. Taken together, these findings suggest that ASB4 may
mediate vascular differentiation through its ligase activity.
However, few putative ASB4 substrates or in vivo functions are
known.
Based on the high expression levels of Asb4 in the developing
placenta, coinciding with the role of ASB4 in vascular differen-
tiation [15], we reasoned that any putative substrates would share
expression patterns and function within in the developing
vasculature. Inhibitor of DNA binding 2 (ID2) is a tightly
regulated mediator of placental development and vascular
differentiation [25–27]. Further, ID2 is involved in other vascular
events, including angiogenesis [26] and tumor cell migration and
invasion [28]. ID2 is part of the anti-differentiation ID protein
family, which shares significant structural similarity to the basic-
helix-loop-helix (bHLH) family of proteins but lacks the basic
domain [29]. ID proteins block the transcription of pro-
differentiation elements by preventing bHLH dimerization and
consequent translocation into the nucleus [30]. Due to the spatial
and temporal overlap and the functional contrast between these
two proteins, we hypothesized that ASB4 negatively regulates
placental endothelial differentiation via and degradation of ID2.
We also hypothesized that ASB4’s inhibition of ID2 would have a
net pro-differentiation effect, and that loss of Asb4 would impair
vascular differentiation within the developing placenta.
In this report, we investigated the role of ASB4 in TB cell
differentiation and function and identified ID2 as a substrate of
ASB4s ubiquitin ligase activity. Placentas isolated from Asb42/2
mice exhibited vascular differentiation defects, dysmorphic
placental vessels, vascular dysfunction, and spontaneous abortion
in a subset of fetuses. Using cell culture models, we found that
ASB4 directly interacted with ID2, leading to ID2’s ubiquitination
and subsequent degradation in JAR cells. Further, ASB4
promoted aspects of placental cell differentiation and endothelial
cell replacement and vessel stability. Co-transfecting Asb4 with Id2
mutants that are resistant to proteasomal degradation abolished
these effects. Lastly, pregnant Asb42/2 mice exhibited symptoms
consistent with pre-eclampsia, including proteinuria and hyper-
tension. Together, these findings indicate that ASB4 regulates TB
cell differentiation into placental vasculature through the degra-
dation of ID2 and that loss of Asb4 in the developing placenta
contributes to placental disease.
Methods
Mouse Generation, Blood Pressure, and Proteinuria
The Asb42/2 mouse generation is described by Ferguson [31].
Briefly, exon 1 of Asb4 was flanked by loxP excision sites in the
pAMC vector. Positive recombinants were electroporated into 129
SvEv ES cells and cultured with appropriate selection enzymes. ES
cells were then injected into C57Bl/6 blastocysts and implanted
into pseudopregnant females. The resultant chimera (Asb4flox/+)
was then mated with EIIa-cre mice to excise the loxP sites. These
mice were further bred to 129 SvEv wild-type mice to ensure
germ-line transmission of the deletion and to outbreed the cre
allele, generating Asb4+/2 mice on the 129 SvEv background.
Maternal blood pressure was measured in conscious, pregnant
mice at the gestational stage indicated using a CODA 8 tail-cuff
monitor (Kent Scientific, Torrington, CT, USA). Mice were
habituated to the machine for one day prior to data collection and
assayed for five consecutive days. Urinary creatinine and albumin
protein levels were measured using the Creatinine Companion
and Albuwell M Test kits, respectively (Exocell, Philadelphia, PA,
USA). Urine collection consisted of placing isolated mice in
metabolic cages (a generous gift from Dr. Nobuyo Maeda
[University of North Carolina]) for 24 hours. Food and water
were provided ad libitum, and urine was collected in a
microcentrifuge tube placed below the mesh flooring. Particulate
matters and solids were removed from the samples by benchtop
centrifugation, and urine was stored at 220uC until assayed.
Placental disc invasion was assessed in E17.5 placentas as
described in Dokras et al. [32]. All experiments were approved
by the Institutional Animal Care and Use Committee of the
University of North Carolina at Chapel Hill.
In situ Hybridization, Immunofluorescence, and
Immunohistochemistry
In situ hybridization for Asb4 was performed by the UNC In
Situ Hybridization Core Facility on 16-mm thick cryosections of
placental tissue harvested under RNase-free conditions from E11.5
wild-type mice. To generate the Asb4 probe, a ,900 bp fragment
of Asb4 was TA-cloned into pCRII-TOPO using the primers 59-
CTCCGAGGATGGACGGCATCACTGCCCCTATC-39 and
59-CTCAGGCTGTGCAGCAGGACGC-39. The fragment was
excised using NotI and BamHI restriction enzymes. Sense and
anti-sense probes were generated by transcription with T7 and
Sp6 polymerase, respectively. Probes were digoxigenin-labeled
prior to hybridization.
Immunofluorescence and immunohistochemistry were per-
formed as described in Waldo et al. [33] on placental tissue
sections at the indicated embryonic day. Briefly, tissue was
harvested and either flash frozen or fixed in 4% paraformaldehyde
overnight with subsequent cryoprotection in 30% sucrose.
Samples were embedded in OTC Compound (Sakura Finetek,
Torrance, CA, USA) and sectioned into 6-mm thick slices by the
UNC Histology Research Core Facility. Primary antibodies are as
follows: antibody recognizing mouse ASB4 was generated as in
Ferguson [31]; c-kit (Cell Signaling Technology, Danvers, MA,
USA); PECAM (Becton-Dickinson, San Jose, CA, USA); cytoker-
atin-17, integrin alpha V, and integrin beta 4 (Abcam); ID2 (Cell
Signalling Technology); Von Willebrand factor (Dako, Carpin-
teria, CA, USA); FITC-conjugated Dolichos biflorus agglutinin
(DBA) (Sigma-Aldrich, St. Louis, MO, USA); and phospho-
histone 3 (Millipore, Billerica, MA, USA). Alexa Fluor antibodies
(Invitrogen, Grand Island, NY, USA) and ABC Elite kits and
diaminobenzidine (Vector Labs, Burlingame, CA, USA) were used
to detect primary antibodies. Apoptosis was quantified using the
ASB4 Degradradation of ID2 in the Placenta
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ApopTag In Situ Apoptosis detection kit (Millipore). Hematoxylin
and eosin staining was performed on fixed frozen sections by the
UNC Histology Core Facility. Tissues and cells were imaged on a
Nikon E800 upright fluorescent microscope, and ImageJ (http://
rsbweb.nih.gov/ij/) was used for quantification and intensity
measurements.
Cell Culture and Immunoblotting
JAR choriocarcinoma cells were obtained from ATCC
(Manassas, VA, USA) and maintained in MEM supplemented
with 10% FBS. HEK-293T/17 cells and 2H-11 endothelial cells
were maintained in DMEM supplemented with 10% FBS. 2H-11
cells were conditioned to constitutively ectopically express ASB4
by transfecting cells with p3xFLAG-CMV10-Asb4, and stable
clones were selected with G418 for 12 days. Transgene expression
was confirmed by anti-FLAG immunoblotting. A stable Asb4
knockdown cell line was created in 2H-11 cells using mouse Asb4
shRNA lentiviral particles. Endogenous Asb4 expression was
screened by reverse transcription-PCR. Transfection reactions
were performed using LTX and Plus reagent (Invitrogen)
according to Wolfe [34]. pCMV2B-Asb4 and p3xFLAG-
CMV10-Asb4 were generated and used as described in Ferguson
[31]. Id2-Sport6 and pCS2-Id2 mutants were generous gifts from
Dr. Aaron Ciechanover (Technion-Israel Institute of Technology).
siRNA transfections were performed using X-tremeGENE siRNA
transfection reagent (Roche, Indianapolis, IN, USA) according to
the manufacturer’s instructions. The siAsb4 duplex sequence is as
follows: 59-CCACAAUGCUACCAUCAA-39 and 59-AGUU-
GAUGGUAGCAUUG-39, and siRNA was synthesized and
duplexed by Integrated DNA Technologies (Coralville, IA,
USA). Cell lysis reactions were performed in cell lysis buffer
(50 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM
EGTA) containing 1% Triton (immunoblots) or 0.5% NP-40
(immunoprecipitations). Cell fractionation assays were performed
using NE-PER Nuclear and Cytoplasmic extraction kit (Thermo
Scientific, Rockford, IL, USA) according to the manufacturer’s
protocol. Cycloheximide was used at 50 mM in DMSO. Immu-
noprecipitation reactions were lysed as described above and
crosslinked with 2 mM DSP (dithiobis[succinimidylpropionate])
(Thermo Scientific) for 2 hours at 4uC. Lysates were pre-cleared
with the appropriate species IgG and Protein A/G beads (Santa
Cruz Biotechnology) for 1 hour at 4uC and then incubated with
either anti-c-myc or anti-FLAG affinity gel (Sigma-Aldrich).
Primary antibodies include ID2 (Cell Signaling Technology);
FLAG-HRP, myc-HRP, and GAPDH (Sigma-Aldrich); KDM1
and MEK1 (Abcam, Cambridge, MA, USA); and HA-HRP
(Roche). Proteins were detected using HRP-conjugated, species-
appropriate secondary antibodies (Sigma-Aldrich) and developed
using TMA-6 reagents (Lumigen, Southfield, MA, USA).
In vitro Ubiquitination Assay
Recombinant ID2 was generated using an ID2-GST fusion
construct (pGEX-2T-Id2) graciously supplied by Dr. Antonio
Iavarone (Columbia University) in BL21(DE3)pLysS chemicom-
petent cells (Agilent Technologies, Santa Clara, CA, USA).
Recombinant ASB4 was generated by ectopically expressing
p3xFLAG-CMV10-Asb4 in HEK-293T/17 cells. E1 (Ube1), E2
(UbcH5a), ATP, and ubiquitin were purchased from Boston
Biochem (Cambridge, MA, USA). The reaction buffer was as
follows: 50 nM E1, 2.5 mM E2, 2.5 mM ASB4, 5 mM ID2,
2.5 mM ATP, 50 mM Tris, pH 7.5, 50 mM KCl, 0.2 mM DTT,
and 250 mM ubiquitin. Reactions were performed at 37uC for 1
hour.
Placental Cell Differentiation Assays
Trophoblast stem cells (TBSCs) were isolated as previously
described [35] from E7.5 embryos. Cells were grown for 6–8
weeks under normal culture conditions to minimize spontaneous
differentiation. Cells were cultured for 72 hours without serum and
then visualized for the presence of trophoblast giant cells, a
hallmark of TBSC differentiation in culture. JAR cells were
induced to secrete human chorionic gonadotropin (hCG) using
N(6),2’-O-dibutyryladenosine 39:59 cyclic monophosphate
(dbcAMP, Sigma-Aldrich) at 1 mM for 24 hours as described in
Hohn et al. [36]. hCG was measured using an ELISA (DRG
International, Mountainside, NJ, USA), and concentrations were
normalized to cell number. The JAR cell-mediated apoptosis of
2H-11 endothelial cells was evaluated based on Chen et al. [37],
using the TUNEL-based ApopTag staining kit (Millipore) as an
index of apoptosis. To assay endothelial network stability mediated
by placental cells, we adapted the JAR cell/endothelial tube
association assay from Aldo et al. [38], using 2H-11 endothelial
cells as our vascular network substrate. JAR cells were transfected
as indicated, then plated upon 2H-11 cells that had formed tube-
like networks. Total area of the JAR/2H-11 network was
measured using ImageJ and quantified.
Unless otherwise noted, statistical analysis for all quantification
was performed using a two-tailed, unpaired Student’s t-Test. p
values are reported in the respective figure legends.
Results
ASB4 is Expressed in Undifferentiated TB Cells and is
Required for Placental Differentiation
Asb4 is localized to areas of high vascular activity and is highly
expressed in the developing placenta [15,31]. ID2 is also critical in
the early development of the placenta, including the maturation of
the placental vasculature [26]. Therefore, we hypothesized that
ASB4 would be an important modulator of differentiation in the
placental vasculature. As shown in Figure 1A (4x magnification)
and 1A’ (20x magnification), Asb4 mRNA was only expressed in
the labyrinth zone of E11.5 placentas. This zone exhibits high
vascular activity [39] and contains the reservoir of TB cells that
cross the junctional zone into the maternal decidua as they mature
into functional endothelial-like cells [40,41]. This observation
supports our hypothesis that ASB4 is involved in early vascular
differentiation events in the placenta.
To test whether ASB4 is expressed in differentiating cells
committing to a vascular lineage, we examined placentas at E11.5,
when stem cells undergo both self-renewal and differentiation and
the cells adopting a vascular lineage migrate from the stem cell
niche [42]. Wild-type placental tissue sections were co-labeled for
ASB4 and markers of various stages of TB-to-endothelial
differentiation. ASB4 co-localized with markers of pluripotent,
cells, specifically in a subset of cells expressing the general stem cell
marker c-kit (Figure 1B) [43]. At this stage in mouse placental
development, invading and differentiating trophoblasts express c-
kit, but terminally differentiated trophoblast giant cells and
spongiotrohoplasts do not. Further, c-kit and its ligand SCF are
implicated have been implicated as being required for trophoblast
spreading and implantation, due to their role in trophoblast
differentiation [44]. In addition, ASB4 also co-localized with a
subset of PECAM-positive cells (Figure 1B’), suggesting that ASB4
is involved with cells that are differentiating into vascular lineages
at this time point. Further supporting a specific role in early
vascularization, ASB4 did not co-localize with cytokeratin 17,
which is a marker of mature placental endothelial-like cells
(Figure 1B’’).
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Because ASB4 co-localized with early markers of the endothe-
lium, we hypothesized that Asb4 deletion would lead to functional
consequences later in development. Specifically, if ASB4 promoted
TB-to-endothelial cell differentiation, then placentas of Asb42/2
mice should have less mature endothelium than those of wild-type
mice. Placentas from wild-type and Asb42/2 mice were examined
at E17.5 and labeled for cytokeratin 17 (Cyto17) to visualize
differentiated, mature endothelial-like cells. In wild-type mice,
there abundant Cyto17 expression in the lining of the vessels,
while in Asb42/2 mouse placentas there were fewer mature
Cyto17-positive cells (Figure 2A), and this decrease was not due to
impaired proliferation or increased apoptosis (Figure S1). During
normal gestation, placental cells undergoing TB-to-endothelial
differentiation undergo integrin ‘‘switching’’ [45], in which
Figure 1. ASB4 is expressed in the developing placental vasculature. A) Asb4 mRNA is expressed only in the labyrinth zone of developing
placentas. In situ hybridization was performed on E11.5 placental sections and imaged with bright field microscopy. Wide-field (4x, A) and higher
magnification (20x, A’) anti-sense (AS)-probed sections illustrate Asb4 localized to the labyrinth zone. A sense probe was used as a negative control
(A’’). B) ASB4 is expressed in a subset of c-kit-positive and PECAM-positive cells but not mature cytokeratin 17-expressing cells. E11.5 placental
sections were probed with markers of stem cells (c-kit, B), endothelial cells (PECAM, B’), and differentiated TB cells (cytokeratin 17, B’’) and
fluorescently imaged at 20x magnification. These images were then merged to show co-localization. ASB4 only co-localizes with cells expressing c-kit
and PECAM (arrows) but not cytokeratin 17 (filled arrows). There are also subsets of c-kit or PECAM positive cells that ASB4 did not co-localize at this
stage (filled arrows).
doi:10.1371/journal.pone.0089451.g001
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undifferentiated TB cells that adopt a vascular phenotype express
beta 4 integrins. Later in gestation, when blood vessels have
differentiated, beta 4 integrins are turned off, and alpha V integrin
is highly expressed [42,46], consistent with what we see in our
wild-type mice (Figure 2B, top panels). Asb42/2 placentas failed to
express integrin alpha V, but maintained beta 4 integrin
expression late in gestation (Figure 2B, bottom panels), consistent
with a failure of the placenta to undergo integrin switching,
indicating an immature and undifferentiated placenta. Placental
disc invasion, during which the fetal components of the placenta
extend and expand into the maternal decidual layers, was more
shallow in Asb42/2 placentas compared with wild-type mice
(Figure 2C) further confirming that placental development is
compromised in Asb42/2 mice in a manner that is consistent with
abnormal differentiation [32]. Additional observations indicate
that the vasculature expressed markers of injury and dysfunction in
near-term (E17.5) Asb42/2 placentas (Figure S2A) and were
mislocalized within the junctional zone rather than the stage-
appropriate outer deciduas (Figures S2B and S2C). These results
indicate that differentiation defects in Asb42/2 placentas may have
deleterious effects that are observed into late gestation.
Because Asb42/2 placentas showed signs of early differentiation
defects and impaired vascularization (Figures 2A, B), we examined
ID2 expression due to its anti-differentiation role in the placenta
[25]. We hypothesized that ID2 expression would be increased in
the Asb42/2 placenta due to ID2’s anti-differentiation role in the
placenta, and thus might underlie the observed differentiation
defects in Asb42/2 placentas. In wild-type mice, ID2 expression is
downregulated as TB cells differentiate. However, in whole
placental cell lysates at E12.5, placentas from Asb42/2 mice have
a ,2 fold increase in ID2 expression compared with placentas
from wild-type mice (Figure 3A), and this finding is confirmed by
immunofluorescence in E13.5 placentas (Figure 3B). These data
indicate that a subset of TB cell remain undifferentiated in Asb42/
2 placentas, and provide evidence that ASB4 may mediate ID2
expression in the placenta.
ASB4 Negatively Regulates ID2 Expression through
Polyubiquitination and Proteasome Dependant
Degradation
Given our observation that ID2 was significantly upregulated in
Asb42/2 placentas, we hypothesized that ID2 may be a substrate
of ASB4s ubiquitin ligase activity. To test this hypothesis, wild-type
Id2 was co-transfected with Asb4 in JAR cells, and ID2 expression
was examined. JAR cells are a desirable cell type because they do
not express endogenous ID2 or ASB4, allowing us to modulate
both proteins without endogenous protein interference. Because
ID2 is rapidly turned over by myriad other proteins, resulting in a
very short half-life (Figure S4B and [47]), we added a low dose of
Figure 2. Asb42/2 placentas express markers of undifferentiated vasculature and TB cells. A) Placentas lacking Asb4 have reduced
cytokeratin 17 expression in near-term placentas. E17.5 placental sections from wild-type and Asb42/2 mice were labeled with cytokeratin 17
(cyto17), a marker of terminally differentiated endothelial-like TB cells. Blood vessels (BVs) in Asb42/2 placentas display reduced cytokeratin 17
labeling compared with BVs in wild-type placentas. B) Placentas from E15.5 wild-type and Asb42/2 placentas were labeled for integrin alpha V, a
marker of mature, terminally differentiated TB cells and integrin beta 4, a marker of immature, undifferentiated TB cells. Wild-type placentas express
alpha V but not beta 4 integins. Cells in Asb42/2 placentas retain integrin beta 4 expression and fail to express integrin alpha V. C) Placental disc
invasion is reduced in Asb42/2 mothers at E17.5, indicating restricted trophoblast expansion. The ratio of the placental disc (P) to the total placenta
(the sum of the decidua (De) and the placental disc) is decreased in Asb42/2 placentas compared to wild-type placentas, indicating a defect in TB cell
invasion and migration.
doi:10.1371/journal.pone.0089451.g002
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MG-132 to experiments in Figure 4A-E to slow proteasomal
degradation events and visualize ID2 protein expression. ASB4
degraded ID2 in a dose-dependent manner in Asb4 and Id2 co-
transfected JAR cells (Figure 4A). To test whether ID2 expression
increased in the absence of ASB4, we transfected Id2 into 2H-11
endothelial cells that stably overexpressed Asb4. ID2 expression
increased when co-transfected with increasing amounts of an
siRNA duplex targeting Asb4 (siAsb4) (Figure 4B). To determine
whether ASB4 binds directly to ID2, we performed co-immuno-
precipitation assays using co-transfected 3x-FLAG-tagged Asb4
and 6x-myc-tagged Id2 in JAR cells. As shown in Figure 4C, ASB4
was detected when ID2 was immunoprecipitated and, conversely,
ID2 was detected when ASB4 was immunoprecipitated
(Figure 4D). Further, we observed a dose response of the ID2-
ASB4 interaction in 2H-11 cells that had increasing amounts of
Id2 transfected in (Figure 4E). Together, these data show that in
placental cells, ASB4 can mediate ID2 expression and that ASB4
and ID2 interact with each other.
Because ASB4 is an E3 ligase, we hypothesized that ASB4
regulates ID2 protein levels by polyubiquitinating ID2 and
targeting it for proteasomal degradation. To test this hypothesis,
we first co-transfected HA-tagged ubiquitin and myc-tagged Id2 in
2H-11 cells that either express endogenous Asb4 or have
constitutively knocked down Asb4 expression to levels undetectable
at either the transcript or protein level. We immunoprecipitated
ID2 and blotted for HA, expecting a ubiquitin ‘‘smear’’ if ID2 was
modified by polyubiquitination. As shown in Figure 4F, ID2
ubiquitination increased dramatically in cells that expressed Asb4,
compared to cells that do not express Asb4. We then tested
whether ASB4 could directly ubiquitinate ID2 by performing an
in vitro ubiquitination assay. We combined recombinant ID2 with
ASB4 and the minimal components required for ubiquitination
and saw that ASB4 ubiquitinated ID2 four-fold more than the
reaction absent of ASB4 (Figure 4G, lane 6 versus lane 3).
Importantly, these reactions were performed in the absence of
Roc1/Rbx1, the RING-finger protein that associates with ASB4,
indicating that ASB4 does not require a RING-finger protein for
ubiquitination. Previous reports into the mechanism of ID2
ubiquitination have demonstrated that ID2 is only susceptible to
N-terminal ubiquitination [47]. To determine whether ID2’s N-
terminus is sensitive to ASB4-mediated degradation, we co-
expressed ASB4 with ID2 mutants that lack all lysine residues (LL-
ID2) or have 6x-myc tags on either the N-terminus (degradation
resistant, DR-ID2) or C-terminus (degradation sensitive, DS-ID2)
in JAR cells. Only the N-terminally tagged ID2 (DR-ID2)
expression level remained unchanged in the presence of ASB4
(Figure S3), indicating that ASB4 mediates ID2 degradation via N-
terminal ubiquitination.
To confirm our hypothesis that ASB4 degrades ID2 in a
proteasome-dependent manner, we completely abolished protea-
somal activity with a high dose of MG-132 to cells ectopically
expressing ID2 and either ASB4 or vector control and compared
ID2 expression to cells that were not treated with MG-132. In cells
treated with DMSO, ASB4 expression led to reduced expression of
ID2 as in Figure 4A. While a high dose of MG-132 slightly
increased total ID2 expression in the absence of ASB4, this
increase was not diminished by the co-expression of ASB4 in the
presence of MG-132 indicating that ID2 is degraded via the
proteasome (Figure S4A). Further, when cells ectopically express-
ing ASB4 and ID2 were treated with cycloheximide to block
protein translation, the half-life of ID2 decreased in the presence of
ASB4 (Figure S4B). To ensure that the reduction in ID2
expression in the soluble fraction assayed above was not caused
by ASB4 inducing ID2 translocation to an insoluble part of the
cell, we performed a cell fractionation assay (Figure S4C). There
was no observable accumulation of ID2 in any of the cell fractions
when co-expressed with ASB4, suggesting that ID2 is not
Figure 3. ID2 expression increases in placentas that lack Asb4. A) Lysates from three E13.5 wild-type and Asb42/2 placentas were
immunoblotted against ID2 (top panel, asterisk denotes nonspecific band) and quantified (bottom panel). p,0.01. JAR-WCL = whole cell lysates
transfected with Id2 or vector and run as a positive immunoblotting control. B) E12.5 sections from wild-type and Asb42/2 placentas were labeled for
ID2 (left panel), confirming that wild-type TB cells at this stage have low ID2 expression while ID2 expression is dramatically greater in Asb42/2
placentas. 100x magnification.
doi:10.1371/journal.pone.0089451.g003
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translocated to other insoluble fractions of the cell upon treatment
with ASB4.
ASB4 Mediates Placental Cell Differentiation and
Function in vitro
In culture, TB cells can induce endothelial turnover [37] and
increase the stability of endothelial cell networks [38], recapitu-
lating the in vivo events that occur when TB cells are differentiating
into endothelial-like cells. Because Asb42/2 placentas express
markers of undifferentiated TB cells (Figure 2), we hypothesized
that ASB4 would increase the JAR cell-meditated apoptosis of 2H-
11 endothelial cells as well as the vascular stability of vessel-like
networks formed by 2H-11 cells in culture. We observed that JAR
cells transfected with ASB4 induced 2H-11 endothelial cells to
apoptose 3-fold more than vector control cells. Co-expression of
wild-type ID2 did not attenuate apoptosis, but JAR cells co-
expressing DR-ID2 and ASB4 resulted in significantly fewer
TUNEL-positive 2H-11 cells compared with JAR cells that were
only transfected with ASB4. Of note, DR-ID2 and ASB4 co-
expression elevated apoptosis compared with vector control cells,
but this was significantly less than cells that did express ASB4
alone (Figure 5A, B). These data demonstrate that ASB4 promotes
a functional vascular phenotype that recapitulates in vivo endothe-
lial replacement with differentiating TB cells and that ID2
represses this effect.
Figure 4. ASB4 negatively regulates ID2 expression through polyubiquitination and associates with ID2 in JAR cells. A) ASB4
represses ID2 expression in a dose-dependent manner. Wild-type Id2 and vector, 0.5, or 2 mg of Asb4 were co-transfected in JAR cells. ID2 expression
decreases as the ASB4 expression increases. B) ID2 expression increases as ASB4 expression decreases. 2H-11 cells that constitutively express high
levels of ectopic ASB4 were transfected with Id2 and either a scrambled nucleotide siRNA duplex (siScr) or increasing doses (0.15 nM, 0.5 nM) of
siAsb4 duplex. As ASB4 expression decreases, ID2 expression concurrently increases. C and D) ID2 and ASB4 associate in JAR cells. 3xFLAG-tagged
Asb4 and 6xmyc-tagged Id2 were co-transfected in JAR cells. Lysates were pre-cleared with species-specific IgG and Protein A/G agarose beads were
run with these reactions as a control against non-specific binding. Pre-cleared lysates were either immunoprecipitated with anti-myc- or anti-FLAG -
conjugated agarose beads and blotted for FLAG or myc, respectively (C, D). Gels were stained with coomassie post-transfer as a loading control for
immunoprecipitations. Input represents 2.5% of total lysate. ASB4 is detected in ID2 immunoprecipitation; conversely, ID2 is detected with ASB4
immunoprecipitation. E) 2H-11 cells that stably express FLAG-tagged Asb4 were transfected with increasing amounts of myc-tagged Id2. Cells were
lysed and pre-cleared as in C and D, then immunoprecipitated with anti-myc conjugated agarose beads and then blotted for FLAG. FLAG expression
increases in parallel with myc expression, indicating specific interaction between ID2 and ASB4. F) ID2 ubiquitination increases in cells with ASB4
expression. Wild-type Id2 and HA-tagged ubiquitin were transfected into either 2H-11 cells that express endogenous Asb4 or 2H-11 cells that have
Asb4 constitutively knocked down. ID2 was immunoprecipitated using anti-ID2 and then blotted against HA. Reactions were blotted on the same
membrane. Input represents 2.5% of total lysate. Ubiquitination of ID2 increases in endothelial cells that express ASB4 compared with cells that do
not. G) ASB4 directly ubiquitinates ID2 in vitro. Recombinant ID2 was incubated with recombinant ASB4, and components of the reaction as
indicated. Reactions were resolved on SDS-PAGE gels and immunoblotted against ID2. ID2 is ubiquitinated approximately four-fold more with ASB4
than without (lane 3). Quantification of ubiquitination is fold change relative to lane 5 (without ID2).
doi:10.1371/journal.pone.0089451.g004
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Previous reports demonstrated that endothelial cells induce TB
migration in culture and that TB cells stabilize these endothelial
vascular networks [38], representing a model of the in vivo events
that occur during TB differentiation [41]. To examine whether
ASB4 could promote TB cell stabilization of endothelial cell
networks, we measured the ability of JAR cells transfected with
Asb4 and Id2 to form stable vascular networks over time, using
branching 2H-11 tube-like structures as the strata upon which
JAR cells could migrate to and stabilize. In isolation, 2H-11 cells
plated on Matrigel consistently form branching tube-like structures
within approximately four hours [48] but devolve into spheroid
cluster of cells within 16 hours (data not shown). However, the
addition of trophoblast cells can stabilize these networks for days
and even weeks in culture [38]. Therefore, we hypothesized that
Asb4-transfected JAR cells would stabilize these 2H-11 cell
networks for significantly longer than vector-transfected JAR
control cells. JAR cells expressing ASB4, either alone or co-
transfected with wild-type Id2, were able to maintain and stabilize
the 2H-11 vascular networks well past 16 hours, when vector
control cell networks had destabilized (Figure 5C, D). Cells co-
transfected with Asb4 and DR-Id2 quickly and significantly
destabilized 2H-11 networks at 16 hours and were indistinguish-
able from control networks after 48 hours. These results indicate
that ASB4 promotes TB endothelial-like cell function in vitro and
that ASB4 mediates these effects by degrading ID2, since DR-ID2
attenuates this ASB4-mediated effect in placental cells.
Because ASB4 mediates vascular differentiation in ES cells [15]
and we have demonstrated that ASB4 negatively regulated the
anti-differentiation protein ID2 (Figure 4A, B), we hypothesized
that ASB4 would mediate placental cell differentiation through the
regulation of ID2 and tested this hypothesis in vitro. First, TBSCs
were isolated from the extraembryonic ectoderm of early post-
implantation (E7.5) wild-type and Asb42/2 embryos and cultured
on a feeder layer of mitotically inactivated MEFs, which promote
the long-term maintenance and proliferation of undifferentiated
stem cells [15]. Large-scale multipotent differentiation is expected
for the first several passages, so cultures were grown 6–8 weeks
prior to serum-withdrawal. Terminally differentiated cells were
sub-cultured out, leaving only the undifferentiated embryoid
bodies of TBSCs. Although the factors required for TBSC-to-
endothelial transformation are not yet know, TBSCs readily
differentiate into trophoblast giant cells (TGCs) [35]. Based on
previous work from this laboratory [49], we used serum
withdrawal to promote TBSC differentiation. Thus, we used the
appearance of TGCs as an index of TBSC differentiation. After
serum withdrawal for 72 hours, we visualized the isolated cells with
bright-field microscopy. As shown in Figure 6A, wild-type TBSCs
largely differentiated into large, multinucleated TGCs, which were
morphologically very different from the small, clustered, undiffer-
entiated TBSCs that form embryoid bodies as seen in Asb42/2
cells (right panel). Further, differentiated TGCs laid flat on the
culture dish, while undifferentiated embryoid bodies had raised
edges and appeared more convex on the culture dish, allowing for
easy identification.
To determine whether ASB4’s influence on TB cell differenti-
ation involves ID2, we examined human chorionic gonadotropin
(hCG) secretion, a well-established marker of trophoblast differ-
entiation [36], in JAR cells that ectopically express ASB4 and ID2.
hCG secretion was stimulated via the addition of dbcAMP to the
growth medium following the indicated transfection for 48 hours
and was subsequently measured in the medium by ELISA. ASB4
stimulated hCG production approximately 2 fold compared with
Figure 5. ASB4 promotes JAR cell-mediated endothelial apoptosis and stabilization of endothelial cell networks. A) JAR cells
expressing ASB4 promote 2H-11 cell apoptosis. JAR cells were transfected with vector, Asb4, Asb4 and wild-type Id2, or Asb4 and DR-Id2 prior to being
seeded on top of 2H-11 monolayers. TUNEL-positive cells were counted and are presented as the percent of total endothelial cells within the field in
panel B. Asb4-transfected cells increase apoptosis of the underlying endothelial cells, even when transfected with wild-type Id2. DR-Id2 co-transfected
with Asb4 inhibits JAR-mediated 2H-11 apoptosis. * p,0.01 as compared to vector/vector. { p,0.01 compared to Asb4-only transfection. C) JAR cells
transfected with Asb4 promote endothelial tube stability. 2H-11 cells were placed on Matrigel and allowed to form tube-like networks. JAR cells
transfected as in A were then plated on the networks, and total network area was measured at the times indicated. JAR cells expressing DR-ID2
destabilize 2H-11 cell networks at 16 hours, while cells expressing ASB4 or ASB4 and wild-type ID2 maintained the size of these 2H-11 cell networks
compared to vector transfected cells at 48 hours after plating (D).* p,0.05, *** p,0.01 as compared to vector/vector.
doi:10.1371/journal.pone.0089451.g005
ASB4 Degradradation of ID2 in the Placenta
PLOS ONE | www.plosone.org 8 February 2014 | Volume 9 | Issue 2 | e89451
the vector control. Co-transfecting wild-type Id2 with ASB4 did
not abolish hCG production, but co-transfection of Asb4 and DR-
Id2 prevented hCG stimulation (Figure 6B). Together with data in
Figure 5, these results illustrate that ASB4 promotes placental cell
differentiation and function in vitro, and that ID2 mutants resistant
to ASB4-mediated degradation can inhibit the differentiation and
function of TB cells in vitro.
Asb42/2 Mice Phenocopy Human Patients with Pre-
eclampsia
Because our data indicate that ASB4 mediates placental cell
differentiation and function (Figures 4 and 5), and that Asb4
deletion has negative consequences in the placental vasculature
throughout development (Figure 2 and Figure S2), we investigated
whether the placental abnormalities found in Asb42/2 mouse
placentas contributed to the placenta-specific disease pre-eclamp-
sia, whose pathogenesis may stem from abnormal placental
vascular development [6]. Asb42/2 female mice produced
significantly smaller litter sizes compared with wild-type female
mice (Figure 7B) due to spontaneous abortion mid-gestation
(Figure 7A). Similarly, Asb4+/2 breeding pairs produced non-
Mendelian ratios of pups that were significantly skewed toward
higher numbers of wild-type animals at the expense of Asb42/2
pups (Figure 7C). When investigating the source of lethality in the
Asb42/2 pregnancies, we observed that fetal growth halted at
approximately E10.5 to E11.5 in a subset of Asb42/2 embryos.
These embryos lacked functioning placental vascularization
(Figure 7A, and data not shown), which may contribute to the
abortion and fetal reabsorption seen in Asb42/2 embryos [4].
Because ID2 expression is elevated in trophoblast cells placentas
of women with pre-eclampsia [25] and Asb42/2 mouse placentas
(Figure 2D, E), combined with the vascular defects observed in
Asb42/2 placentas (Figure 2A, Figure S2), we investigated whether
our Asb42/2 mice shared traits with human patients with pre-
eclampsia, which is widely believed to be a disease of the placental
vasculature [14]. Two hallmarks of pre-eclampsia are maternal
hypertension and proteinuria during late-stage pregnancy. Preg-
nant Asb42/2 female mice had increased blood pressure during
late gestation (E14-term), as compared to both gestationally age-
matched wild-type mice and Asb42/2 mice during the first week of
gestation (Figure 7D). Further, pregnant Asb42/2 female mice had
higher ratios of albumin:creatinine protein in their urine during
late stage pregnancy than wild-type mice (Figure 7E). Together,
these results suggest that Asb42/2 mice phenocopy human pre-
eclampsia and may serve as a model for both early placental
vascularization and human placental disease.
Discussion
Strict control over the vascular patterning of the placenta is
critical for both maternal and fetal survival [50]. Aberrant
differentiation events early in development negatively affect the
later formation of the vasculature [41], but relatively little is known
what drives early differentiation events. Although none of the
limited data that identify putative substrates or functions of ASB4
support a central function for ASB4 in vivo [15,16,22,51,52], prior
work from this laboratory has shown that ASB4 is involved in early
vascular differentiation and is highly expressed in the developing
placenta [15]. Therefore, we utilized Asb42/2 mice, in conjunc-
tion with placenta-derived cells, to determine the function of ASB4
during placental vascular differentiation. Consistent with our
previous work [15], we found that ASB4 is largely localized to the
early endothelium in the placenta. We also found that Asb4
deletion induces the expression of markers of undifferentiation in
the placenta, including the anti-differentiation protein ID2. Based
on this data, along with the expression pattern of various markers
of TB cells and endothelial differentiation in Asb42/2 placentas,
we determined that ASB4 is involved in the earlier stages of
differentiation events, and the consequences of Asb4 deletion
persist into later stages of gestation resulting in insufficient
placental vascularization.
Due to the limited information found in the literature,
identifying a substrate of ASB4s ligase activity was central to this
investigation. Taking a candidate approach, we reasoned that any
ASB4 substrate would have to share its narrow spatiotemporal
expression pattern, contribute to vascular phenotypes, and be
involved in differentiation. We determined that the ID family of
proteins would fulfill these criteria [53]. The ID proteins (ID1 to
ID4) are known to mediate differentiation and cell cycle control,
which impact cell functions such as metastasis, angiogenesis,
apoptosis, and maintaining stemness [30,53–55]. Within these
processes, there is significant, but not ubiquitous redundancy
Figure 6. ASB4 promotes TB cell differentiation in vitro. A) TB stem cells (TBSCs) were isolated from wild-type and Asb42/2 extraembryonic
ectoderm at E7.5. Cells isolated from each conceptus were cultured in isolation, and these data represent 4 unique populations of cells for each
genotype. Serum withdrawal induces the formation of large, multinucleated trophoblast giant cells (TGCs, arrows) that differentiate from TBSCs
(asterisks). As shown, wild-type TBSCs largely differentiate into TGCs (left panel) while Asb42/2 cells remain in undifferentiated embryoid bodies (right
panel). MEF-feeder cells are indicated by filled arrows. Dashed outlines indicate the border of non-MEF cell clusters. B) JAR cells were transfected to
express vector, Asb4, or Asb4 co-transfected with vector, wild-type Id2, or degradation-resistant Id2 (DR-Id2). ASB4 induced hCG secretion, and co-
expression of wild-type ID2 with ASB4 did not change hCG secretion compared to ASB4 expression alone. DR-ID2 prevented dcbAMP-induced hGC
section, with concentrations of hCG no different than vector/vector transfected cells. * p,0.01 compared with vector/vector.
doi:10.1371/journal.pone.0089451.g006
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between the individual ID proteins [56–59]. Further, ID proteins,
and ID2 specifically, are known to be tightly regulated by E3
ligases [47,60,61]. Therefore, ID2 was chosen for investigation in
this study due to its involvement in differentiation [54], vascular
development [62], and placental maturation [25]. Using cell
culture and biochemical techniques, we determined that ASB4 can
directly negatively regulate ID2 expression.
Placental remodeling requires three unique vascular events for
proper function: TBSC differentiation, replacement of endotheli-
um with trophoblast cells, and vascular stabilization to form high
capacity vessels [41]. Possibly because the JAR cell line was isolated
from CTB cells in choriocarcinomas, these cells can be induced to
mimic in vivo cells under certain conditions. We adapted several
methods to assess cell differentiation and function in culture, and
whether ASB4 promoted these events through the inhibition of
ID2. Although these methods do not completely recapitulate in vivo
events, they collectively indicate that ASB4 has a pro-vascular
differentiation function in placental cells. By ectopically expressing
ASB4 in the JAR cells, we were able to determine that ASB4
promotes all three aspects of placental vascular remodeling. In
addition, using isolated TBSCs, we were able to observe primary
TB cell differentiation in culture. TBSCs that lack Asb4 remained in
undifferentiated embryoid bodies, in contrast to wild-type TBSCs
which differentiated into TGCs upon serum withdrawal. Because
exact markers of TBSC and endothelial differentiation are not well
defined in the placenta, future studies will be needed to more
precisely address these differentiation events.
Using Asb42/2 mice as a model for ASB4 function in vivo, we
explored the phenotypic consequences of Asb4 deletion, focusing
particularly on the early placenta. Although the majority of Asb42/
2 embryos survived to term, all had placentas with varying degrees
of vascular dysfunction. Further, embryonic lethality occurred in a
subset of Asb42/2 embryos at approximately E10.5 due to gross
endothelial disruption in the placenta. Furthermore, placental
vascular dysfunction in Asb42/2 placentas also had deleterious
effects on pregnant mice, phenocopying women with pre-
eclampsia. Though extremely common, little is known about the
pathogenesis of pre-eclampsia [63] and to date there is no cure
other than delivery of the placenta. Both third trimester
hypertension and proteinuria, hallmarks of pre-eclampsia, were
recapitulated in Asb42/2 mothers. This disease state, in conjunc-
tion with the differentiation defects in the placenta of Asb42/2
mice, provides a unique model of early vascular development.
Ultimately, this model of pre-eclampsia and vascular dysfunction
may be used to investigate therapeutic strategies for treating pre-
eclampsia and other diseases of the placenta.
Supporting Information
Figure S1 Diminished mature vasculature in Asb42/2
placentas is not due to increased apoptosis or abnormal
proliferation. E15.5 placental sections from wild-type and
Asb42/2 mice were evaluated for aberrant proliferation or
apoptosis using phospho-histone H3 (pH3) or TUNEL, respec-
tively. In both cases, no discernible differences were noted between
genotypes. BV; blood vessel. Arrows denote TUNEL-positive cells.
(TIF)
Figure 7. Pregnant Asb42/2 mice display symptoms of pre-eclampsia. A) A subset of Asb42/2 embryos dies in utero. Asb42/2 littermates are
shown at E12.5, illustrating the lack of placental vasculature and dramatically reduced fetal growth in a subset of Asb42/2 embryos. The resultant
average litter size, taken from more than 25 litters from each group, is quantified in B. C) Heterozygous breeding results in a lower than expected
number of Asb42/2 pups (p,0.01, Fisher’s exact test). Pregnant Asb42/2 mice have significantly elevated mean blood pressure (D) and urine-
albumin:urine-creatinine (E) in the third trimester of pregnancy compared with both Asb42/2 mice in the first week of pregnancy and wild-type mice
in the third week of pregnancy. * p,0.01.
doi:10.1371/journal.pone.0089451.g007
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Figure S2 Asb4 deletion induces vascular dysfunction
and mislocalization of blood vessels in the placenta. A)
Near-term (E17.5) placental sections were harvested and labeled
with von Willibrand factor to measure thrombus response and
DBA to determine uterine natural killer cell response. Asb42/2
placentas display elevated thrombus/thrombosis response (left
panel) compared with wild-type placentas, indicating damaged
vasculature. Further, there is a dramatic increase in activated
uterine natural killer cells (right panel) in Asb42/2 tissues,
indicating elevated macrophage and immune response, compared
to wild-type tissue. B) E17.5 placental sections were stained with
hematoxylin and eosin and examined for gross morphology. Blood
vessels (arrows) were counted and classified based on their location
in the labyrinth (LZ), junctional (JZ), or decidual (DE) zones.
Blood vessels in wild-type placentas are seen at the edge of the
deciduas in, whereas significantly more vessels in Asb42/2
placentas are located in the junctional zone, at the expense of
the decidual zone, which is quantified in C, indicating that
vascular invasion/migration is defective in the absence of Asb4. *
p,0.01 compared to wild-type.
(TIF)
Figure S3 N-terminally tagged ID2 is resistant to ASB4-
mediated degradation. A) JAR cells were transfected with
wild-type Id2, Id2 lacking all lysine residues (LL-Id2), or Id2 with
6xMyc tags on either the N-terminus (DR-Id2) or the C-terminus
(DS-Id2) in the absence or presence of ASB4. ASB4 is unable to
degrade DR-ID2 but can efficiently degrade other ID2 mutants,
which is quantified in B. * p,0.01 compared to wild-type ID2.
(TIF)
Figure S4 ASB4 degrades ID2 in a proteasome-depen-
dant manner, and does not affect ID2 cellular location.
A) JAR cells co-transfected with Id2 and either vector or wild-type
Asb4 were treated with DMSO or MG-132. While overall ID2
expression increases in the presence of MG-132, ID2 expression
decreases only in the presence of ASB4 in DMSO-treated cells,
suggesting that ID2 is sensitive to proteasomal degradation when
co-expressed with ASB4. B) JAR cells were transfected as in A,
then treated with cycloheximide for the indicated times. In the
presence of ASB4 (right panel above, dashed line and open
diamonds in graph), ID2 half-life is shortened from 40.2 minutes
to 33 minutes compared to cells that only express ID2 (left panel
above, solid line and solid boxes in graph) indicating that ASB4
mediates ID2 protein expression. C) ID2 sub-cellular localization
is not altered in the presence of ASB4. JAR cells transfected with
Id2 and either vector or wild-type Asb4 were fractionated into the
whole cell lysate (WCL), cytoplasmic (Cyto), nuclear (Nuc), and
Triton-insoluble pellet (Pel) fractions. In all fractions, ID2
expression decreases in the presence of ASB4.
(TIF)
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